MedPath

Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF

Not Applicable
Withdrawn
Conditions
Preterm Labor
Interventions
Procedure: GBS screening
Registration Number
NCT03122704
Lead Sponsor
Manh Tuong Ho
Brief Summary

This is a cross - sectional study to determine the prevalence of GBS infection and associated factors in preterm labor women conceived through ART.

221 subjects will be involved.

Detailed Description

Pregnant women at 20 0/7 to 36 6/7 weeks of gestation, conceived through ART, with signs and symptoms of preterm labor will be recruited.

Anal - vaginal fluid samples will be taken by 2 cotton swabs from each participant for culture. Digital examination will be performed after that. Only participants fulfilling all the study's eligible criteria will be interviewed face-to-face with a questionnaire.

The samples will be sent immediately to My Duc hospital laboratory or will be stored in Stuart-Amies medium in \< 4 hours. All culture results are interpreted based on Clinical and Laboratory Standards Institute (CLSI) in 2012.

Statistical analysis was performed by Statistical Package for the Social Sciences (SPSS) v.20 and chi-square test. A p-value of \< 0.05 was considered as statistically significant.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

To be eligible for enrolment into this trial, subject must fulfil all of the following criteria, unless specified otherwise

  • Being conceived through IVF

  • Moderate uterine contractions (2 contractions per 10 minutes, duration < 30 seconds)

  • 20 0/7 to 36 6/7 weeks of gestation

  • Intact membrane

  • Cervical dilation ≤ 3 cm

  • Willing to participate into the study

Exclusion Criteria

To be eligible for enrolment in this study each subject must not meet any of the following criteria:

  • Having had intercourse during 24 hours before
  • Being suspected of amniotic leakage
  • Rupture of membrane identified by direct observation through speculum examination of amniotic fluid flow from cervix
  • Vaginal bleeding
  • Being suspected of placenta abruption, placenta previa
  • Having been treated with antibiotics within 1 week before
  • Vaginal douche within 48 hours before
  • Having used vaginal medicines during 48 hours before
  • Having vaginal ultrasound shortly before
  • Urine culture positive with GBS

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Group B Streptococcus (GBS) screeningGBS screeningVaginal and anal swab of patients will be screened for GBS screening
Primary Outcome Measures
NameTimeMethod
Percentage of women with GBS infection7 days after swab taken

Number of women with GBS infection divided by total number of women under screening

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

My Duc Hospital

🇻🇳

Ho Chi Minh City, Tan Binh District, Vietnam

© Copyright 2025. All Rights Reserved by MedPath